German biotech firm BioNTech (22UAy.DE), has agreed to acquire domestic peer CureVac, for about $1.25 billion worth of BioNTech shares, it said on Thursday, to boost its work on new mRNA-based cancer treatments.
Under the deal, which pairs two former rivals in the race to develop COVID-19 vaccines, CureVac shareholders stand to receive a premium of 55% over the three-month average share price, and leave them with a stake of about 4%-6% in BioNTech, the suitor said.
CureVac's Frankfurt-listed shares surged 27% to a five-month high, valuing the company at €1.04 billion ($1.2 billion), while BioNTech shares were down 2%.
The deal further underscores BioNTech's long-term pursuit of new cancer treatments as it aims to show that its success as Pfizer's COVID-19 vaccine partner, which left its balance sheet flush with billions of euros in cash, was not a fluke.
"With the acquisition, BioNTech aims to strengthen the research, development, manufacturing, and commercialization of investigational mRNA-based cancer immunotherapy," the company said.
CureVac opted to focus on oncology about a year ago when it agreed to sell its remaining influenza and COVID-19 vaccine development to alliance partner GSK.
It had previously cut jobs as it sought to move beyond its failure to develop an mRNA-based COVID vaccine during the pandemic.
GERMAN BIOTECH CHAMPION
The agreement is also set to end CureVac's years-long legal fight over alleged mRNA patent infringement by BioNTech and for a share of vaccine revenues, where CureVac has made little progress.
CureVac shares were worth as much as €120 in December 2020 on hopes it would develop a COVID vaccine, more than double their initial public offer value in August of that year. They are now trading at €4.65.
BioNTech won a major shot in the arm for its cancer drug activities last week when Bristol Myers Squibb agreed to pay up to $11.1 billion to jointly develop a next-generation cancer immunotherapy that could take on rival Merck & Co's best-selling drug Keytruda.
Each CureVac share will be exchanged for about $5.46 in BioNTech American depositary shares, or ADS, but subject to a so-called collar mechanism, BioNTech said.
If the 10-day volume-weighted average price of BioNTech ADS shortly before the closing of the offer exceeds $126.55, the exchange ratio would be 0.04318, and if the price is lower than $84.37, the exchange ratio would be 0.06476.
BioNTech said the deal was supported by SAP SE co-founder and football investor Dietmar Hopp, who holds a stake of about 37% in CureVac.
The German government, owner of about 13% in CureVac for its financial backing during the pandemic, said it welcomed in principle the creation of a "new German biotech champion", and that it would review the offer.
Australia has launched legal action against U.S. chemicals giant 3M, seeking more than $1.4 billion over contamination linked to firefighting foam co...
The trial of a 21-year-old accused of planning an Islamist attack at a Taylor Swift concert in Vienna entered its final day on Thursday (28 May), with...
The Islamic Revolution’s Guards Corps of Iran (IRGC) said it carried out a retaliatory attack on a U.S. airbase in the early hours of Thursday. The ...
U.S. President Donald Trump has publicly endorsed Armenian Prime Minister Nikol Pashinyan ahead of Armenia’s parliamentary elections on 7 June, back...
Start your day informed with the AnewZ Morning Brief. Here are the top stories for 28 May, covering the latest developments you need to know....
Countries worldwide sought to prevent the further spread of the hantavirus on Thursday, after an outbreak on a cruise ship, by tracking those who had disembarked before the virus was detected and anyone who had close contact with them since.
The global health crisis gave one of the world’s most secretive states cover to intensify a lethal domestic crackdown.
The United States officially left the World Health Organization on 22 January, triggering a financial and operational crisis at the United Nations health agency. The move follows a year of warnings from global health experts that a U.S. exit could undermine public health at home and abroad.
The World Health Organization (WHO) has warned that Afghanistan is facing a worsening humanitarian and health crisis in 2025, with millions of returning refugees expected to stretch the country’s already fragile health system.
Chinese investigators have uncovered hidden tunnels, missing worker trackers and fake underground walls during an initial investigation into the country’s deadliest mining disaster in more than 15 years.
Dozens of people were killed in Israeli strikes on Lebanon on Tuesday, Lebanese officials said, straining a fragile ceasefire agreed between the countries in April. The attacks came as Iran accused the U.S. of violating a separate ceasefire with strikes near the Strait of Hormuz.
The new AnewZ documentary, TARGET: Yerevan, builds its explosive case on exclusive, secret recordings originally published by Minval Politika.
The visit by U.S. Secretary of State Marco Rubio to Armenia marks one of the clearest signs yet of Washington’s growing interest in the South Caucasus.
As climate pressures and urbanisation accelerate worldwide, governments are increasingly investing in smart cities and villages to build more sustainable and resilient communities. Across the world, digital technologies are reshaping how cities and rural areas are planned and managed.
Australia has launched legal action against U.S. chemicals giant 3M, seeking more than $1.4 billion over contamination linked to firefighting foam containing PFAS chemicals, widely known as “forever chemicals”.
The World Health Organisation has warned that the risk of a widening Ebola outbreak in the Democratic Republic of the Congo (DRC) has escalated to “very high” at national level.
A luxury polar expedition vessel linked to a hantavirus outbreak has arrived in Rotterdam, where health authorities have placed the final 27 people on board into quarantine and have begun containment measures.
Medical teams are being rushed to eastern Democratic Republic of Congo (DRC) following a fast-moving Ebola outbreak that has already caused dozens of suspected deaths and raised fears of wider regional spread.
The World Health Organisation’s designation of the Bundibugyo Ebola virus outbreak as a Public Health Emergency of International Concern (PHEIC) is a stark reminder that Ebola remains a persistent global health threat rather than a disease of the past.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment